Nuclear reprocessing, weapons tests, and nuclear accidents, such as the 2011 catastrophe in Japan, release xenon
radioisotopes into the atmosphere.
When a tumour cell is located, the antibody binds to the cell surface and releases the caged
radioisotope into the tumour cell.
Not exact matches
Radioisotope power systems convert heat from the natural radioactive decay of the isotope plutonium - 238
into electricity.
NASA's
Radioisotope Power System (RPS) program, managed by NASA Glenn Research Center in Cleveland, is funding the development of new, higher efficiency thermoelectric materials that could be incorporated
into a next - generation enhanced MMRTG that would provide about 25 percent more power at the start of a typical mission, and 50 percent more power at the end of a mission.
Nearly half a century ago, NASA developed
radioisotope thermal generators (RTGs) that convert the heat from radioactive decay
into electricity.
In an attempt to do this, the researchers used a technique known as radioimmunotherapy in which
radioisotopes (unstable elements that release radiation) mounted on antibodies (protein molecules akin to infection search - and - destroy missiles) are injected
into the body.
«This strategy may allow better penetration of larger tumours because the
radioisotope can make its way deep
into the tumour before releasing the toxic radioactivity trapped inside.»
Large and small animal nuclear medicine is available and is a subspecialty of radiology in which
radioisotopes (compounds containing radioactive forms of atoms) are put
into the body to evaluate organ function or localize bone disease such as stress fractures or tumor metastasis.